Versor Investments’s Intersect ENT, Inc XENT Stock Holding History

Versor Investments’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,323,482	Closed	-$93.1M	–	967
2022 Q1	$93.1M	Buy	3,323,482 +148,385	+5%	+$4.07M	3.48%	12
2021 Q4	$86.7M	Buy	3,175,097 +916,989	+41%	+$24.9M	2.62%	12
2021 Q3	$61.4M	Buy	+2,258,108	New	+$55.8M	1.89%	22

Versor Investments's XENT Position: Q2 2022 in Review

Versor Investments sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 3,323,482 shares — an estimated $93.1M sold.

Versor Investments first reported a position in XENT in Q3 2021 and held it in 3 quarters. The position peaked at $93.1M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Versor Investments reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Versor Investments sold 3,323,482 Intersect ENT, Inc shares in Q2 2022, an estimated $93.1M.
Versor Investments first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 3 quarters.
Versor Investments's Intersect ENT, Inc position peaked at $93.1M in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Versor Investments's 13F filing for Q2 2022, filed 27 Jul 2022.